This class has been associated with neurological adverse reactions including tremors, ataxia, and seizures. The safety of NEXGARD SPECTRA in puppies less than 8 weeks of age has not been evaluated.Īfoxolaner is a member of the isoxazoline class. The safety of NEXGARD SPECTRA Chewable Tablets has not been evaluated in breeding, pregnant or lactating dogs. Intestinal Nematodes Treatment and Prevention:ĭogs may be exposed to and can become infected with hookworms, roundworms and whipworms throughout the year. If treatment is delayed, whether by a few days or many, immediate treatment with NEXGARD SPECTRA and resumption of the recommended dosing regimen will minimize the opportunity for the development of adult heartworms. To establish a treatment routine, it is recommended that the same day or date be used each month. NEXGARD SPECTRA should be administered at monthly intervals beginning within 1 month of the dog’s first exposure to mosquitoes and continuing for 6 months after the dog’s last exposure to mosquitoes (see EFFICACY). Severe cases of generalized demodicosis may be difficult to cure. As demodicosis is a multi-factorial disease, where possible, it is advisable to also treat any underlying disease appropriately. Skin scrapings should be done to assess the response to treatment. NEXGARD SPECTRA should be administered monthly for 3 months. To minimize the likelihood of flea reinfestation, it is important to treat all animals within a household with an approved flea control product.Īdministration of NEXGARD SPECTRA should coincide with the time of year the ticks are active. To be effective NEXGARD SPECTRA should be administered every 30 days.įor prevention of flea infestation, NEXGARD SPECTRA should be administered ideally just before fleas become active. If a dose is missed, administer NEXGARD SPECTRA and resume an every-30-day dosing regimen. If it is suspected that any of the dose has been lost, or vomiting occurs within 2 hours of administration, redose with another full dose. NEXGARD SPECTRA can be administered with or without food.Ĭare should be taken that the dog consumes the complete dose, and treated animals should be observed for a few minutes to ensure that part of the dose is not lost or rejected. Milbemycin Oxime per chewable tablet (mg) Dosage and Administration NEXGARD SPECTRA is given orally every 30 days, at the recommended dosage of 2.5 - 5 mg/kg of afoxolaner and 0.5 - 1 mg/kg of milbemycin oxime. the reduction of Borrelia burgdorferi infections as a direct result of killing adult Ixodes scapularis vector ticks. the treatment and control of intestinal nematode infections caused by adult hookworms (Ancylostoma caninum), adult roundworms (Toxocara canis and Toxascaris leonina) and adult whipworms (Trichuris vulpis) the prevention of heartworm disease (Dirofilaria immitis) (see CAUTIONS), the treatment of demodicosis caused by Demodex canis, the treatment and control of Dermacentor variabilis (American Dog Ticks), Ixodes scapularis (Blacklegged Ticks), and Amblyomma americanum (Lone Star Ticks), the treatment and control of flea (Ctenocephalides felis) infestations, NEXGARD SPECTRA chewable tablets are indicated in dogs and puppies 8 weeks of age or older for: NexGard Spectra Chewable Tablets 150/30 mg (XL) Indications Each chewable tablet contains the active ingredients, afoxolaner (an ectoparasiticide of the isoxazoline family) and milbemycin oxime (an endoparasiticide belonging to the group of macrocyclic lactones). Afoxolaner and Milbemycin Oxime Chewable TabletsĭESCRIPTION: NEXGARD SPECTRA is a soft, beef-flavoured chewable tablet.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |